355 related articles for article (PubMed ID: 37331550)
1. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
[TBL] [Abstract][Full Text] [Related]
2. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.
Li H; Shen Y; Yu Z; Huang Y; He T; Xiao T; Li Y; Xiong J; Zhao J
Front Endocrinol (Lausanne); 2021; 12():731187. PubMed ID: 35095752
[TBL] [Abstract][Full Text] [Related]
5. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes.
Duan S; Geng L; Lu F; Chen C; Jiang L; Chen S; Zhang C; Huang Z; Zeng M; Sun B; Zhang B; Mao H; Xing C; Zhang Y; Yuan Y
Diabetes Metab Syndr; 2024 Feb; 18(2):102963. PubMed ID: 38373384
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
[TBL] [Abstract][Full Text] [Related]
8. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
[TBL] [Abstract][Full Text] [Related]
9. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
Front Immunol; 2020; 11():2073. PubMed ID: 32983156
[No Abstract] [Full Text] [Related]
10. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
[TBL] [Abstract][Full Text] [Related]
11. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
Lee YH; Kim KP; Park SH; Kim DJ; Kim YG; Moon JY; Jung SW; Kim JS; Jeong KH; Lee SY; Yang DH; Lim SJ; Woo JT; Rhee SY; Chon S; Choi HY; Park HC; Jo YI; Yi JH; Han SW; Lee SH
Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31598726
[TBL] [Abstract][Full Text] [Related]
12. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study.
Basu M; Pulai S; Neogi S; Banerjee M; Bhattacharyya NP; Sengupta S; Mukhopadhyay P; Ray Chaudhury A; Ghosh S
BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36517108
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of α1-MG and URBP in early diabetic renal impairment.
Zhou Y; Zhang Y; Chen J; Wang T; Li H; Wu F; Shang J; Zhao Z
Front Physiol; 2023; 14():1173982. PubMed ID: 37929213
[No Abstract] [Full Text] [Related]
15. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
[TBL] [Abstract][Full Text] [Related]
16. Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy.
Shimizu M; Furuichi K; Kitajima S; Toyama T; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Miyagawa T; Hara A; Iwata Y; Sakai N; Kitagawa K; Yoshimura M; Yokoyama H; Wada T
BMC Nephrol; 2021 Sep; 22(1):319. PubMed ID: 34560842
[TBL] [Abstract][Full Text] [Related]
17. Kidney biopsy can help to predict renal outcomes of patients with type 2 diabetes mellitus.
Kim WJ; Oh T; Heo NH; Kwon K; Shin GE; Jeong SH; Lee JH; Park S; Cho NJ; Gil HW; Lee EY
Kidney Res Clin Pract; 2024 Jan; ():. PubMed ID: 38212871
[TBL] [Abstract][Full Text] [Related]
18. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
19. The association of plasma NT-proBNP level and progression of diabetic kidney disease.
Zhao Y; Zhao L; Wang Y; Zhang J; Ren H; Zhang R; Wu Y; Zou Y; Tong N; Liu F
Ren Fail; 2023 Dec; 45(1):2158102. PubMed ID: 36820611
[TBL] [Abstract][Full Text] [Related]
20. Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021.
Zeng YQ; Yang YX; Guan CJ; Guo ZW; Li B; Yu HY; Chen RX; Tang YQ; Yan R
BMC Endocr Disord; 2022 Jun; 22(1):168. PubMed ID: 35773653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
